Study authors sought to determine whether surgical antimicrobial prophylaxis administration following cord clamping led to an increase risk of surgical site infections.
The new doses of Vanco Ready include 150mL, 250mL, and 350mL premixed bags containing 750mg, 1.25g, and 1.75g of vancomycin, respectively.
The use of prophylactic oral antibiotic in the day prior to elective colon surgery is associated with a reduced incidence of surgical-site infections.
According to Mylan, the administration of the recalled product may lead to “serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic reactions, and microvascular obstruction, including pulmonary embolism.”
The FDA has expanded the approval of Sivextro.
Treatment considerations for vulnerable patients with pemphigus during the COVID-19 pandemic are outlined.
Risk for infection influenced by defect size and use of complex layered closure in closed surgical wounds.
The delayed onset of a severe cutaneous reaction to hydroxychloroquine means clinicians may continue to see patients presenting with the symptoms.
Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage before and personalizing prophylaxis for carriers after elective colorectal surgery reduces the risk of surgical site infections.
Using oral antibiotics when possible and limiting the durations of vancomycin treatment may decrease vancomycin-associated acute kidney injury in patients with acute bacterial skin and skin structure infections.
